.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Queensland Health
Chubb
Deloitte
Moodys
Federal Trade Commission
UBS
Cantor Fitzgerald
Cipla
Dow

Generated: December 18, 2017

DrugPatentWatch Database Preview

CORLOPAM Drug Profile

« Back to Dashboard

Which patents cover Corlopam, and when can generic versions of Corlopam launch?

Corlopam is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in CORLOPAM is fenoldopam mesylate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fenoldopam mesylate profile page.

Summary for CORLOPAM

Drug patent expirations by year for CORLOPAM

Pharmacology for CORLOPAM

Drug ClassDopaminergic Agonist
Mechanism of ActionDopamine Agonists

Medical Subject Heading (MeSH) Categories for CORLOPAM

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
HospiraCORLOPAMfenoldopam mesylateINJECTABLE;INJECTION019922-001Sep 23, 1997APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Daiichi Sankyo
Johnson and Johnson
Merck
McKesson
Colorcon
Fish and Richardson
Julphar
Queensland Health
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot